Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Mitchison

Showing results (171-180 of 190) with videos related to

Pageof 19
Sort By:
American Journal of Respiratory and Critical Care Medicine|June 25, 1998
Rifapentine and isoniazid in the continuation phase of treating pulmonary tuberculosis. Initial reportC M Tam, S L Chan, C W Lam, et al.
The Journal of Antimicrobial Chemotherapy|December 6, 2001
The early bactericidal activity of a low-clearance liposomal amikacin in pulmonary tuberculosisP R Donald, F A Sirgel, A Venter, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|June 21, 2001
The early bactericidal activity of amikacin in pulmonary tuberculosisP R Donald, F A Sirgel, A Venter, et al.
American Journal of Respiratory and Critical Care Medicine|October 6, 1997
The early bactericidal activity of ciprofloxacin in patients with pulmonary tuberculosisF A Sirgel, F J Botha, D P Parkin, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|April 6, 2000
Rifapentine and isoniazid in the continuation phase of a 6-month regimen. Interim report: no activity of isoniazid in the continuation phaseC M Tam, S L Chan, K M Kam, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|February 22, 2011
Moxifloxacin and pyrazinamide susceptibility testing in a complex case of multidrug-resistant tuberculosisN A Feasey, M Pond, D Coleman, et al.
Tubercle and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|February 1, 1992
The early bactericidal activity of rifabutin measured by sputum viable counts in Hong Kong patients with pulmonary tuberculosisS L Chan, W W Yew, W K Ma, et al.
The Journal of Antimicrobial Chemotherapy|December 1, 1993
The early bactericidal activity of rifabutin in patients with pulmonary tuberculosis measured by sputum viable counts: a new method of drug assessmentF A Sirgel, F J Botha, D P Parkin, et al.
International Journal of Antimicrobial Agents|January 1, 1994
Comparison of Chinese and Western rifapentines and improvement of bioavailability by prior taking of various mealsS L Chan, W W Yew, J H Porter, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|August 2, 2002
The early bactericidal activity of streptomycinP R Donald, F A Sirgel, A Venter, et al.
Pageof 19

Showing results (171-180 of 190) with videos related to

Sort By:
Pageof 19
American Journal of Respiratory and Critical Care Medicine|June 25, 1998
Rifapentine and isoniazid in the continuation phase of treating pulmonary tuberculosis. Initial reportC M Tam, S L Chan, C W Lam, et al.
The Journal of Antimicrobial Chemotherapy|December 6, 2001
The early bactericidal activity of a low-clearance liposomal amikacin in pulmonary tuberculosisP R Donald, F A Sirgel, A Venter, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|June 21, 2001
The early bactericidal activity of amikacin in pulmonary tuberculosisP R Donald, F A Sirgel, A Venter, et al.
American Journal of Respiratory and Critical Care Medicine|October 6, 1997
The early bactericidal activity of ciprofloxacin in patients with pulmonary tuberculosisF A Sirgel, F J Botha, D P Parkin, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|April 6, 2000
Rifapentine and isoniazid in the continuation phase of a 6-month regimen. Interim report: no activity of isoniazid in the continuation phaseC M Tam, S L Chan, K M Kam, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|February 22, 2011
Moxifloxacin and pyrazinamide susceptibility testing in a complex case of multidrug-resistant tuberculosisN A Feasey, M Pond, D Coleman, et al.
Tubercle and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|February 1, 1992
The early bactericidal activity of rifabutin measured by sputum viable counts in Hong Kong patients with pulmonary tuberculosisS L Chan, W W Yew, W K Ma, et al.
The Journal of Antimicrobial Chemotherapy|December 1, 1993
The early bactericidal activity of rifabutin in patients with pulmonary tuberculosis measured by sputum viable counts: a new method of drug assessmentF A Sirgel, F J Botha, D P Parkin, et al.
International Journal of Antimicrobial Agents|January 1, 1994
Comparison of Chinese and Western rifapentines and improvement of bioavailability by prior taking of various mealsS L Chan, W W Yew, J H Porter, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|August 2, 2002
The early bactericidal activity of streptomycinP R Donald, F A Sirgel, A Venter, et al.
Pageof 19